Quadrant Capital Group’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5
Closed -$443 2039
2026
Q1
$443 Sell
5
-5
-50% -$431 ﹤0.01% 2633
2025
Q4
$785 Buy
+10
New +$761 ﹤0.01% 2616
2025
Q2
Sell
-120
Closed -$14.2K 2097
2025
Q1
$14.2K Buy
120
+38
+46% +$5.18K ﹤0.01% 2135
2024
Q4
$10.8K Sell
82
-4
-5% -$491 ﹤0.01% 2098
2024
Q3
$11.2K Sell
86
-23
-21% -$2.71K ﹤0.01% 2115
2024
Q2
$9.46K Sell
109
-279
-72% -$29.2K ﹤0.01% 2140
2024
Q1
$42.6K Buy
388
+111
+40% +$11.2K ﹤0.01% 1485
2023
Q4
$29K Buy
277
+232
+516% +$22.6K ﹤0.01% 1649
2023
Q3
$4.73K Sell
45
-22
-33% -$2.82K ﹤0.01% 2190
2023
Q2
$8.61K Sell
67
-213
-76% -$32.5K ﹤0.01% 2058
2023
Q1
$48.9K Hold
280
0.01% 1256
2022
Q4
$46.5K Sell
280
-50
-15% -$7.83K 0.01% 1206
2022
Q3
$46K Buy
330
+318
+2,650% +$58K 0.01% 1085
2022
Q2
$2K Buy
12
+3
+33% +$657 ﹤0.01% 2239
2022
Q1
$2K Buy
9
+3
+50% +$815 ﹤0.01% 2165
2021
Q4
$2K Buy
+6
New +$1.88K ﹤0.01% 2156
2021
Q2
Sell
-6
Closed -$1K 2493
2021
Q1
$1K Buy
6
+3
+100% +$825 ﹤0.01% 2251
2020
Q4
$1K Hold
3
﹤0.01% 2150
2020
Q3
$1K Hold
3
﹤0.01% 2015
2020
Q2
$1K Hold
3
﹤0.01% 2089
2020
Q1
$1K Buy
+3
New +$740 ﹤0.01% 2015

Other funds holding MLAB

Quadrant Capital Group's MLAB Position: Q2 2026 in Review

Quadrant Capital Group sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 5 shares — an estimated $443 sold.

Quadrant Capital Group first reported a position in MLAB in Q1 2020 and held it in 21 quarters. The position peaked at $48.9K in Q1 2023. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Quadrant Capital Group reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 5 Mesa Laboratories shares in Q2 2026, an estimated $443.
  • Quadrant Capital Group first reported a position in Mesa Laboratories in Q1 2020 and held it in 21 quarters.
  • Quadrant Capital Group's Mesa Laboratories position peaked at $48.9K in Q1 2023.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.